Corcept Therapeutics, Inc. (CORT)
110.16
-3.21
(-2.83%)
USD |
NASDAQ |
Oct 16, 16:00
109.84
-0.32
(-0.29%)
After-Hours: 20:00
Corcept Therapeutics Free Cash Flow (Quarterly) : 31.02M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 31.02M |
| March 31, 2026 | -16.97M |
| December 31, 2025 | 38.40M |
| September 30, 2025 | 54.48M |
| June 30, 2025 | 43.88M |
| March 31, 2025 | 4.666M |
| December 31, 2024 | 59.18M |
| September 30, 2024 | 72.19M |
| June 30, 2024 | 40.77M |
| March 31, 2024 | 23.76M |
| December 31, 2023 | 5.887M |
| September 30, 2023 | 52.87M |
| June 30, 2023 | 42.18M |
| March 31, 2023 | 25.96M |
| December 31, 2022 | 33.36M |
| September 30, 2022 | 33.30M |
| June 30, 2022 | 18.02M |
| March 31, 2022 | 35.24M |
| December 31, 2021 | 49.36M |
| September 30, 2021 | 48.54M |
| June 30, 2021 | 44.22M |
| March 31, 2021 | 25.30M |
| December 31, 2020 | 34.64M |
| September 30, 2020 | 29.73M |
| June 30, 2020 | 53.14M |
| Date | Value |
|---|---|
| March 31, 2020 | 33.23M |
| December 31, 2019 | 48.32M |
| September 30, 2019 | 38.14M |
| June 30, 2019 | 25.14M |
| March 31, 2019 | 23.42M |
| December 31, 2018 | 21.41M |
| September 30, 2018 | 44.46M |
| June 30, 2018 | 15.15M |
| March 31, 2018 | 34.35M |
| December 31, 2017 | 24.85M |
| September 30, 2017 | 10.84M |
| June 30, 2017 | 15.37M |
| March 31, 2017 | 9.451M |
| December 31, 2016 | 4.494M |
| September 30, 2016 | 8.845M |
| June 30, 2016 | 1.583M |
| March 31, 2016 | 3.275M |
| December 31, 2015 | 4.18M |
| September 30, 2015 | 0.883M |
| June 30, 2015 | -0.139M |
| March 31, 2015 | -1.811M |
| December 31, 2014 | -1.403M |
| September 30, 2014 | -5.945M |
| June 30, 2014 | -9.032M |
| March 31, 2014 | -11.17M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Eli Lilly & Co. | 4.475B |
| Pfizer Inc. | 302.00M |
| Phibro Animal Health Corp. | 5.225M |
| Liquidia Corp. | 69.01M |
| Illumina, Inc. | 159.00M |